Dental and Medical Problems

Dent Med Probl
Index Copernicus (ICV 2020) – 128.41
MEiN – 70 pts
CiteScore (2021) – 2.0
JCI – 0.5
Average rejection rate (2021) – 81.35%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – quarterly

Download PDF

Dental and Medical Problems

2016, vol. 53, nr 2, April-June, p. 278–281

doi: 10.17219/dmp/62076

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Role of Stabilized Stannous Fluoride in Halitosis Prevention and Treatment – Literature Review

Rola stabilizowanego fluorku cyny w zapobieganiu i leczeniu halitozy – przegląd piśmiennictwa

Ewa Iwanicka-Grzegorek1,A,B,D,F, Adam Kolenda2,B, Tomasz Konopka3,E, Agnieszka Beata Mielczarek1,E,F

1 Department of Conservative Dentistry, Medical University of Warsaw, Warsaw, Poland

2 Department of Prosthetic Dentistry, Medical University of Warsaw, Warsaw, Poland

3 Department of Periodontology, Wrocław Medical University, Wrocław, Poland

Abstract

Halitosis, being an intensive and unpleasant smell from the mouth, constitutes a serious problem for the person suffering from it. In most cases, the cause is originally related to the oral environment and the occurrence of specific bacteria on the tongue. The mechanical elimination of micro-organisms, consisting of tooth brushing, tongue cleaning and dental floss usage, should be supported by chemical compounds with antimicrobial activity. Even though modern knowledge of halitosis’ etiology and diagnosis has widened, the search for the most effective preventive and therapeutic procedures persists. In this paper, the authors explain the antibacterial mechanism of stannous fluoride stabilized with sodium hexametaphosphate. Attention was drawn to the high effectiveness of stannous fluoride in malodor reduction, resulting in effective bactericidal activity, disrupting the ability of bacterial metabolism, inhibiting biofilm formation and neutralizing chemical compounds. The properties of multidirectional divalent tin make toothpastes containing a formula of stannous fluoride stabilized with sodium hexametaphosphate a good alternative to the products currently used in the fight against this pathology.

Key words

oral hygiene, halitosis, toothpastes, stannous fluoride, sodium hexametaphosphate

Słowa kluczowe

higiena jamy ustnej, halitoza, pasty do zębów, fluorek cyny, heksametafosforan sodu

References (20)

  1. Dadamio J., Laleman I., Quirynen M.: The role of toothpastes in oral malodor management. Monogr. Oral Sci. 2013, 23, 45–60.
  2. Zürcher A., Laine M.L., Filippi A.: Diagnosis, prevalence, and treatment of halitosis. Curr. Oral Health Rep. DOI 10.1007/s40496-014-0036-5.
  3. Van Der Sleen M.I., Slot D.E., Van Trijfel E., Winkel E.G., Var der Weijden G.A.: Effectiveness of mechanical tongue cleaning on breath odour and tongue coating: a systematic review. Int. J. Dent. Hyg. 2010, 8, 258–268.
  4. Seemann R., Kison A., Bizhang M., Zimmer S.: Effectiveness of mechanical tongue cleaning on oral levels of volatile sulphur compounds. J. Am. Dent. Assoc. 2001, 132, 1263–1267.
  5. Tomzetich J., Ng S.K.: Reduction of malodor by oral cleansing procedures. Oral Surg. Oral Med. Oral Pathol. 1976, 42, 172–181.
  6. Quirynen M., Zhao H., van Steenberghe D.: Review of the treatment strategies for oral malodour. Clin. Oral Invest. 2002, 6, 1–10.
  7. Nakano Y., Yoshimura M., Koga T.: Methyl mercaptan production by periodontal bacteria. Int. Dent. J. 2002, 52 (Suppl 3), 217–220.
  8. Parkinson C.R,. Jeffery P., Milleman J.L., Milleman K.R., Mason S.: Confirmation of efficacy in providing relief from the pain of dentin hypersensitivity of an anhydrous dentifrice containing 0.454% with or without stannous fluoride in an 8-week randomized clinical trial. Am. J. Dent. 2015, 28,190–196.
  9. O’Toole S., Mistry M., Mutahar M., Moazzez R., Bartlett D.: Sequence of stannous and sodium fluoride solutions to prevent enamel erosion. J. Dent. 2015, 43, 1498–1503.
  10. Haraszthy V.I., Zambon J.J., Sreenivasan P.K.: The antimicrobial efficacy of commercial dentifrices. Gen. Dent. 2010, 58, 50–55.
  11. Andres C.F., Shaffer J.C., Windeler A.S.: Comparison of the antibacterial properties of stannous fluoride and sodium fluoride mouthwashes. J. Dent. Res. 1974, 53, 457–460.
  12. Tinanoff N., Klock B., Camosci D.A., Manwell M.A.: Microbiologic effects of SnF2 and NaF mouthrinses in subjects with high caries activity: results after one year. J. Dent. Res. 1983, 62, 907–911.
  13. Niederman R.: Stannous fluoride toothpastes reduce the gingival index more than sodium fluoride toothpastes. Evid. Based Dent. 2007, 8, 74–75.
  14. Ramji N., Baig A., He T., Lawless M.A., Saletta L., Suszcynsky-Meister E., Coggan J.: Sustained antibacterial actions of a new stabilized stannous fluoride dentifrice containing sodium hexametaphosphate. Compendium, 2005, 26, (Suppl. 1), 19–28.
  15. Donovan-Brand R.: A comparison of the breath and antimicrobial efficacies of various antimicrobial systems present in commercial dental products. J. Dent. Res. 2003, 82 (Sp Is), 27.
  16. Feng X., Chen X., Cheng R., Sun L., Zhang Y., He T.: Breath malodor reduction with use of a stannous-containing sodium fluoride dentifrice: A meta-analysis of four randomized and controlled clinical trials. Am. J. Dent. 2010, 23 Sp Is B, 27B–31B.
  17. Blom T., Slot D.E., Quirynen M., Van der Weijden G.A.: The effect of mouthrinses on oral malodor: a systematic review. Int. J. Dent. Hyg. 2012, 10, 209–222.
  18. Raangs G.C., Winkel E.G., van Winkelhoff A.J.: In vitro antimicrobial effects of two antihalitosis mouth rinses on oral pathogens and human tongue microbiota. Int. J. Dent. Hyg. 2013, 11, 203–207.
  19. Haraszthy V.I., Zambon J.J., Sreenivasan P.K.: Evaluation of the antimicrobial activity of dentifrices on human oral bacteria. J. Clin. Dent. 2010, 21, 96–100.
  20. Wigger-Alberti W., Gysen K., Axmann E.M., Wilhelm K.P.: Efficacy of a new mouthrinse formulation on the reduction of oral malodour in vivo. A randomized, double-blind, placebo-controlled, 3 week clinical study. J. Breath Res. 2010, 4, 017102.